Evidence map›Paper›PMID 31243029›Full record

ArticleBMJ open2019

Impact of mobile health applications on self-management in patients with type 2 diabetes mellitus: protocol of a systematic review.

Benard Ayaka Bene, Siobhan O'Connor, Nikolaos Mastellos, Azeem Majeed, Kayode Philip Fadahunsi, John O'Donoghue

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A Mobile App for Diabetes Management: Impact on Self-Efficacy Among Patients with Type 2 Diabetes at a Community Hospital.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Trial
  5. Article
  6. Article
  7. Trust in Medical AI: The Case of mHealth Diabetes Apps.Journal of evaluation in clinical practice · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Benard Ayaka BeneDepartment of Primary Care & Public Health, School of Public Health, Imperial College London, London, UK.ORCID 0000-0003-4545-1836
Siobhan O'ConnorSchool of Health in Social Science, University of Edinburgh, Edinburgh, UK.
Nikolaos MastellosDepartment of Primary Care & Public Health, School of Public Health, Imperial College London, London, UK.
Azeem MajeedDepartment of Primary Care & Public Health, School of Public Health, Imperial College London, London, UK.
Kayode Philip FadahunsiDepartment of Primary Care & Public Health, School of Public Health, Imperial College London, London, UK.ORCID 0000-0003-1470-5493
John O'DonoghueMalawi eHealth Research Centre, University College Cork, Cork, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe emergence of mobile health (mHealth) solutions, particularly mHealth applications (apps), has shown promise in self-management of chronic diseases including type 2 diabetes mellitus (T2DM). While majority of the previous systematic reviews have focused on the effectiveness of mHealth apps in improving treatment outcomes in patients with T2DM, there is a need to also understand how mHealth apps influence self-management of T2DM. This is crucial to ensure improvement in the design and use of mHealth apps for T2DM. This protocol describes how a systematic review will be conducted to determine in which way(s) mHealth apps might impact on self-management of T2DM.

methodsThe following electronic databases will be searched from inception to April 2019: PubMed, MEDLINE, EMBASE, Global Health, PsycINFO, CINAHL, The Cochrane Central Register of Controlled Trials, Scopus, Web of Science, ProQuest Dissertations & Theses Global, Health Management Information Consortium database, Google Scholar and ClinicalTrials.gov. The Cochrane risk of bias tool will be used to assess methodological quality. The primary outcome measures to be assessed will be 'change in blood glucose'. The secondary outcomes measures will be 'changes in cardiovascular risk markers' (including blood pressure, body mass index and blood lipids), and self-management practices. Others will include: health-related quality of life, economic data, social support, harms (eg, death or complications leading to hospital admissions or emergency unit attendances), death from any cause, anxiety or depression and adverse events (eg, hypoglycaemic episodes). ETHICS AND DISSEMINATION: This study will not involve the collection of primary data and will not require ethical approval. The review will be published in a peer-reviewed journal and a one-page summary of the findings will be shared with relevant organisations. Presentation of findings will be made at appropriate conferences. TRIAL REGISTRATION NUMBER: CRD42017071106.

Indexed as

Mobile ApplicationsTelemedicineBlood GlucoseDiabetes Mellitus, Type 2HumansQuality of LifeResearch DesignSelf-ManagementSystematic Reviews as TopicTreatment OutcomeBlood Glucosemhealthmobile applicationsmobile healthself-managementsystematic reviewtype 2 diabetes mellitus

Identifiers

PMID31243029
PMCPMC6597642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.